PAM
AGIO icon

Panagora Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Panagora Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Buy
373,931
+135,463
+57% +$4.11M 0.04% 301
2026
Q1 		$8.07M Buy
238,468
+158,628
+199% +$4.5M 0.03% 341
2025
Q4 		$2.17M Buy
+79,840
New +$2.8M 0.01% 549
2025
Q3 		– Sell
-47,190
Closed -$1.57M – 1149
2025
Q2 		$1.57M Sell
47,190
-31
-0.1% -$940 0.01% 533
2025
Q1 		$1.38M Hold
47,221
– – 0.01% 603
2024
Q4 		$1.55M Sell
47,221
-20,764
-31% -$975K 0.01% 569
2024
Q3 		$3.02M Sell
67,985
-106,885
-61% -$4.85M 0.01% 449
2024
Q2 		$7.54M Buy
+174,870
New +$6.31M 0.04% 258
2023
Q2 		– Sell
-20,052
Closed -$461K – 1244
2023
Q1 		$461K Hold
20,052
– – ﹤0.01% 1149
2022
Q4 		$563K Sell
20,052
-4,818
-19% -$136K ﹤0.01% 1116
2022
Q3 		$703K Buy
+24,870
New +$667K ﹤0.01% 1009
2021
Q3 		– Sell
-3,208
Closed -$177K – 1714
2021
Q2 		$177K Buy
3,208
+33
+1% +$1.84K ﹤0.01% 1689
2021
Q1 		$164K Buy
3,175
+2,366
+292% +$117K ﹤0.01% 1769
2020
Q4 		$35K Hold
809
– – ﹤0.01% 2103
2020
Q3 		$28K Hold
809
– – ﹤0.01% 2128
2020
Q2 		$43K Hold
809
– – ﹤0.01% 2012
2020
Q1 		$29K Buy
+809
New +$37.4K ﹤0.01% 1983
2016
Q4 		– Sell
-10,510
Closed -$555K – 2362
2016
Q3 		$555K Hold
10,510
– – ﹤0.01% 1411
2016
Q2 		$440K Sell
10,510
-4,843
-32% -$239K ﹤0.01% 1410
2016
Q1 		$623K Buy
15,353
+14,865
+3,046% +$636K ﹤0.01% 1284
2015
Q4 		$32K Buy
+488
New +$32K ﹤0.01% 2079
2015
Q2 		– Sell
-521
Closed -$49K – 2417
2015
Q1 		$49K Buy
+521
New +$58.4K ﹤0.01% 2095
2014
Q2 		– Sell
-62
Closed -$2K – 2314
2014
Q1 		$2K Buy
+62
New +$2.08K ﹤0.01% 2309

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Panagora Asset Management's AGIO Position: Q2 2026 in Review

Panagora Asset Management increased its Agios Pharmaceuticals (AGIO) stake by 57% in Q2 2026, buying an estimated $4.11M and bringing the position to 373,931 shares worth $13.9M. The position accounts for 0.04% of the portfolio, ranked #301.

Panagora Asset Management first reported a position in AGIO in Q1 2014 and has held it in 23 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Panagora Asset Management held 373,931 shares of Agios Pharmaceuticals worth $13.9M as of Q2 2026.
  • Panagora Asset Management bought 135,463 Agios Pharmaceuticals shares in Q2 2026, an estimated $4.11M.
  • Agios Pharmaceuticals made up 0.04% of Panagora Asset Management's portfolio in Q2 2026, its #301 holding.
  • Panagora Asset Management first reported a position in Agios Pharmaceuticals in Q1 2014 and has held it in 23 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.